Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-15 Sale |
2025-04-17 6:10 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
149,054 | $0.33346 | $49,704 | 6,885,572 (Indirect) |
View |
| 2025-02-11 Sale |
2025-02-12 4:21 pm |
Passage BIO Inc. | PASG | Borthwick Kathleen CFO |
3,183 | $0.5296 | $1,686 | 41,283 (Direct) |
View |
| 2025-01-10 Sale |
2025-01-14 5:17 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
223,219 | $0.63715 | $142,223 | 7,034,626 (Indirect) |
View |
| 2025-01-06 Sale |
2025-01-08 6:09 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
147,024 | $0.70265 | $103,306 | 7,257,845 (Indirect) |
View |
| 2024-12-27 Purchase |
2024-12-31 4:05 pm |
Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner |
373,645 | $0.6451 | $241,038 | 9,256,953 (Indirect) |
View |
| 2024-12-20 Sale |
2024-12-26 4:34 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
230,321 | $0.6 | $138,193 | 7,404,869 (Indirect) |
View |
| 2024-12-09 Sale |
2024-12-11 5:32 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
62,276 | $0.8348 | $51,988 | 7,635,190 (Indirect) |
View |
| 2024-12-04 Sale |
2024-12-06 7:07 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
97,103 | $0.79646 | $77,338 | 7,697,466 (Indirect) |
View |
| 2024-11-25 Purchase |
2024-11-27 6:11 pm |
Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner |
456,353 | $0.62346 | $284,520 | 8,883,308 (Indirect) |
View |
| 2024-09-19 Sale |
2024-09-23 4:51 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
39,300 | $0.71 | $27,903 | 7,794,569 (Indirect) |
View |
| 2024-09-16 Sale |
2024-09-18 6:38 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
200,131 | $0.73315 | $146,727 | 7,833,869 (Indirect) |
View |
| 2024-02-13 Sale |
2024-02-13 7:36 pm |
Passage BIO Inc. | PASG | Borthwick Kathleen SVP, INTERIM CFO |
1,470 | $0.97 | $1,426 | 36,466 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-13 7:34 pm |
Passage BIO Inc. | PASG | Forman Mark S CHIEF MEDICAL OFFICER |
1,638 | $0.97 | $1,589 | 228,631 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-03 4:21 pm |
Passage BIO Inc. | PASG | Forman Mark S Chief Medical Officer |
15,813 | $0.91 | $14,390 | 45,269 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-03 4:20 pm |
Passage BIO Inc. | PASG | Borthwick Kathleen SVP, Interim CFO |
10,672 | $0.91 | $9,712 | 25,936 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-03 4:19 pm |
Passage BIO Inc. | PASG | Cale Edgar B. GC & Corporate Secretary |
15,813 | $0.91 | $14,390 | 45,995 (Direct) |
View |
| 2023-07-28 Sale |
2023-08-01 4:36 pm |
Passage BIO Inc. | PASG | King Simona Chief Financial Officer |
11,453 | $0.88 | $10,079 | 23,994 (Direct) |
View |
| 2023-06-27 Purchase |
2023-06-29 4:42 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
1,192,577 | $0.84 | $1,001,765 | 8,034,000 (Indirect) |
View |
| 2023-06-16 Sale |
2023-06-20 4:10 pm |
Passage BIO Inc. | PASG | Fotopoulos Alexandros Chief Technical Officer |
4,052 | $0.9325 | $3,778 | 53,693 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-15 Option Award |
2025-03-18 5:12 pm |
N/A 2035-03-15 |
Passage BIO Inc. | PASG | Borthwick Kathleen CFO |
278,386 | $0 | 278,386 (Direct) |
View |
| 2025-03-15 Option Award |
2025-03-18 5:11 pm |
N/A 2035-03-15 |
Passage BIO Inc. | PASG | Chou William PRESIDENT AND CEO |
779,533 | $0 | 779,533 (Direct) |
View |
| 2025-03-15 Option Award |
2025-03-18 5:11 pm |
N/A 2035-03-15 |
Passage BIO Inc. | PASG | Cale Edgar B. GC & CORPORATE SECRETARY |
278,386 | $0 | 278,386 (Direct) |
View |
| 2025-02-10 Exercise |
2025-02-12 4:21 pm |
N/A N/A |
Passage BIO Inc. | PASG | Borthwick Kathleen CFO |
8,000 | $0 | 41,283 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 4:41 pm |
N/A 2034-09-30 |
Passage BIO Inc. | PASG | Cale Edgar B. GC & CORPORATE SECRETARY |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 4:35 pm |
N/A 2034-09-30 |
Passage BIO Inc. | PASG | Kassberg Thomas Richard Director |
174,139 | $0 | 174,139 (Direct) |
View |
Ownership |
2024-08-09 5:11 pm |
N/A N/A |
Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner |
0 | $0 | 8,426,955 (Indirect) |
View |
| 2024-05-21 Option Award |
2024-05-23 5:43 pm |
N/A 2034-05-21 |
Passage BIO Inc. | PASG | Countouriotis Athena Director |
47,693 | $0 | 47,693 (Direct) |
View |
| 2024-05-21 Option Award |
2024-05-23 4:56 pm |
N/A 2034-05-21 |
Passage BIO Inc. | PASG | GOWEN MAXINE Director |
47,693 | $0 | 47,693 (Direct) |
View |
| 2024-05-21 Option Award |
2024-05-23 4:55 pm |
N/A 2034-05-21 |
Passage BIO Inc. | PASG | Kapadia Sandip Director |
47,693 | $0 | 47,693 (Direct) |
View |
| 2024-05-21 Option Award |
2024-05-23 4:53 pm |
N/A 2034-05-21 |
Passage BIO Inc. | PASG | Islam Saqib Director |
47,693 | $0 | 47,693 (Direct) |
View |
| 2024-05-21 Option Award |
2024-05-23 4:52 pm |
N/A 2034-05-21 |
Passage BIO Inc. | PASG | Sondhi Dolan Director |
39,092 | $0 | 39,092 (Direct) |
View |
| 2024-05-21 Option Award |
2024-05-23 4:51 pm |
N/A 2034-05-21 |
Passage BIO Inc. | PASG | Porter Derrell Director |
47,693 | $0 | 47,693 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:11 pm |
N/A N/A |
Passage BIO Inc. | PASG | Borthwick Kathleen CFO |
227,000 | $0 | 227,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:09 pm |
N/A N/A |
Passage BIO Inc. | PASG | Forman Mark S CHIEF MEDICAL OFFICER |
203,000 | $0 | 203,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:09 pm |
N/A N/A |
Passage BIO Inc. | PASG | Chou William PRESIDENT AND CEO |
575,000 | $0 | 575,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-19 4:08 pm |
N/A N/A |
Passage BIO Inc. | PASG | Cale Edgar B. GC & CORPORATE SECRETARY |
203,000 | $0 | 203,000 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 7:36 pm |
N/A N/A |
Passage BIO Inc. | PASG | Borthwick Kathleen SVP, INTERIM CFO |
4,000 | $0 | 36,466 (Direct) |
View |
| 2021-08-16 Option Award |
2024-02-13 7:34 pm |
N/A 2031-08-15 |
Passage BIO Inc. | PASG | Forman Mark S CHIEF MEDICAL OFFICER |
170,000 | $0 | 228,631 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 7:34 pm |
N/A N/A |
Passage BIO Inc. | PASG | Forman Mark S CHIEF MEDICAL OFFICER |
5,000 | $0 | 228,631 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 4:21 pm |
N/A N/A |
Passage BIO Inc. | PASG | Forman Mark S Chief Medical Officer |
50,000 | $0 | 45,269 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 4:20 pm |
N/A N/A |
Passage BIO Inc. | PASG | Borthwick Kathleen SVP, Interim CFO |
30,000 | $0 | 25,936 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 4:19 pm |
N/A N/A |
Passage BIO Inc. | PASG | Cale Edgar B. GC & Corporate Secretary |
50,000 | $0 | 45,995 (Direct) |
View |
| 2023-07-28 Exercise |
2023-08-01 4:36 pm |
N/A N/A |
Passage BIO Inc. | PASG | King Simona Chief Financial Officer |
31,250 | $0 | 23,994 (Direct) |
View |
| 2023-07-27 Option Award |
2023-07-31 5:34 pm |
N/A 2033-07-27 |
Passage BIO Inc. | PASG | Sondhi Dolan Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-07-28 Option Award |
2023-07-28 6:34 pm |
N/A 2033-07-27 |
Passage BIO Inc. | PASG | Borthwick Kathleen SVP, Interim CFO |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2023-07-28 6:33 pm |
N/A 2031-12-15 |
Passage BIO Inc. | PASG | Borthwick Kathleen SVP, Interim CFO |
0 | $0 | 173,867 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-20 4:10 pm |
N/A N/A |
Passage BIO Inc. | PASG | Fotopoulos Alexandros Chief Technical Officer |
12,500 | $0 | 53,693 (Direct) |
View |